MA46897A - Insuline dégludec utilisée dans des conditions cardiovasculaires - Google Patents
Insuline dégludec utilisée dans des conditions cardiovasculairesInfo
- Publication number
- MA46897A MA46897A MA046897A MA46897A MA46897A MA 46897 A MA46897 A MA 46897A MA 046897 A MA046897 A MA 046897A MA 46897 A MA46897 A MA 46897A MA 46897 A MA46897 A MA 46897A
- Authority
- MA
- Morocco
- Prior art keywords
- cardiovascular conditions
- insulin degludec
- degludec
- insulin
- cardiovascular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16200906 | 2016-11-28 | ||
| EP17174682 | 2017-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46897A true MA46897A (fr) | 2021-04-28 |
Family
ID=60937677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046897A MA46897A (fr) | 2016-11-28 | 2017-11-28 | Insuline dégludec utilisée dans des conditions cardiovasculaires |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11278596B2 (enExample) |
| EP (1) | EP3544683A1 (enExample) |
| JP (1) | JP7193455B2 (enExample) |
| CN (1) | CN110022935A (enExample) |
| MA (1) | MA46897A (enExample) |
| WO (1) | WO2018096162A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3544683A1 (en) | 2016-11-28 | 2019-10-02 | Novo Nordisk A/S | Insulin degludec in cardiovascular conditions |
| AR112015A1 (es) | 2017-06-09 | 2019-09-11 | Novo Nordisk As | Composiciones sólidas para administración oral |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| CN114096269B (zh) | 2019-07-12 | 2024-06-11 | 诺和诺德股份有限公司 | 高浓度胰岛素制剂 |
| CN113773397B (zh) * | 2020-06-10 | 2023-10-20 | 宁波鲲鹏生物科技有限公司 | 一种德谷胰岛素的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122009000079I2 (de) | 1996-08-30 | 2011-06-16 | Novo Nordisk As Novo Alle | Glp-1 derivate |
| GB0309154D0 (en) * | 2003-01-14 | 2003-05-28 | Aventis Pharma Inc | Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
| AU2004261353B2 (en) | 2003-08-05 | 2009-12-10 | Novo Nordisk A/S | Novel insulin derivatives |
| IN2014KN02335A (enExample) * | 2012-03-28 | 2015-05-01 | Sanofi Sa | |
| US20160296602A1 (en) | 2013-03-20 | 2016-10-13 | Novo Nordisk A/S | Dosing Regimen |
| EP2991672A1 (en) * | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
| MA46890A (fr) | 2016-11-28 | 2021-04-28 | Novo Nordisk As | Insuline degludec pour l'amélioration du contrôle glycémique et la réduction des complications du diabète aigu et à long terme |
| EP3544683A1 (en) | 2016-11-28 | 2019-10-02 | Novo Nordisk A/S | Insulin degludec in cardiovascular conditions |
-
2017
- 2017-11-28 EP EP17825753.1A patent/EP3544683A1/en not_active Withdrawn
- 2017-11-28 US US16/463,598 patent/US11278596B2/en active Active
- 2017-11-28 JP JP2019528489A patent/JP7193455B2/ja active Active
- 2017-11-28 MA MA046897A patent/MA46897A/fr unknown
- 2017-11-28 CN CN201780073496.7A patent/CN110022935A/zh active Pending
- 2017-11-28 WO PCT/EP2017/080600 patent/WO2018096162A1/en not_active Ceased
-
2022
- 2022-02-08 US US17/667,223 patent/US12233114B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN110022935A (zh) | 2019-07-16 |
| US20190374614A1 (en) | 2019-12-12 |
| JP7193455B2 (ja) | 2022-12-20 |
| US11278596B2 (en) | 2022-03-22 |
| WO2018096162A1 (en) | 2018-05-31 |
| US20220160840A1 (en) | 2022-05-26 |
| EP3544683A1 (en) | 2019-10-02 |
| US12233114B2 (en) | 2025-02-25 |
| JP2019535785A (ja) | 2019-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256999B (en) | Diabetes management therapy advisor | |
| ME03384B (me) | Brzodjelujući pripravci inzulina | |
| DK3368085T3 (da) | Modificerede alginater til anti-fibrotiske materialer og anvendelser | |
| MA41188A (fr) | Compositions d'insuline à action rapide | |
| DK2963056T3 (da) | Insulinanalog og anvendelse deraf | |
| EP3227425C0 (en) | LIQUID CLEANING COMPOSITIONS COMPRISING PROTEASE VARIANTS | |
| DK3120239T3 (da) | Fælles bootsekvens til styringsmodul der kan initialiseres i flere arkitekturer | |
| DK3152607T3 (da) | En antiresonant hulkernefiber | |
| EP3314445A4 (en) | COHERENT FABRIC CONNECTION FOR USE IN SEVERAL TOPOLOGIES | |
| IL256939B (en) | Rapid-acting insulin compositions | |
| FR3024271B1 (fr) | Plusieurs tailles de mots codes ecc dans un ssd | |
| HUE055728T2 (hu) | Posztbariatrikus hipoglikémia kezelése exendin(9-39)-el | |
| EP3380616A4 (en) | MANUFACTURE OF VIRUSES IN BIRDS | |
| DK2959455T3 (da) | Forbedringer af eller relaterende til billedbehandling | |
| EP3371825A4 (en) | COMPOSITIONS COMPRISING MATRIX AND CAPSULE MATERIALS FOR USE IN ELECTRONIC DEVICES | |
| DK3229828T3 (da) | Formulering med fast forhold mellem insulin glargin og lixisenatid | |
| EP3307306A4 (en) | GENE EXPRESSION IN BACTEROIDES | |
| EP3444327C0 (en) | Dishwashing tablets | |
| DK3209677T3 (da) | Varianter af gal2-transporter og anvendelser deraf | |
| DK3140050T3 (da) | Dosering med visning | |
| DK3324937T3 (da) | Brugsfærdig bortezomib-opløsning | |
| ITUB20156000A1 (it) | Composizione nematocida e suo utilizzo | |
| MA43704A (fr) | Liraglutide dans des états cardio-vasculaires | |
| DK3369429T3 (da) | Farmaceutisk sammensætning tiltænkt at blive administreret til næseslimhinden | |
| IL253785A0 (en) | Ruthenium and indium binding to gastrins |